The producing organism was isolated from a soil collected in Minato-Ku, Tokyo, Japan, and was identified as Penicillium sp. The slant culture of the producing organism was inoculated into a 500-ml Erlenmeyer flask containing 100ml of a seed medium consisting of glucose 2.0%, Polypepton 0.5%, yeast extract 0.2%, agar 0.1%, KH2PO4 0.1% and MgSO4-7H2O 0.05% (adjusted to pH 6.0 before sterilization).
After incubation at 27°C for 72hours on a rotary shaker, 1 vol.% of the seed culture was inoculated into one hundred 500-ml
Erlenmeyer flasks containing 100 ml each of a producing medium consisting of saccharose 2.0%, glucose 1.0%, corn steep powder 0.5%, meat extract 0.5%, agar 0.1%, KH2PO4 0.1% and CaCO3 0.3% (adjusted to pH 6.0 before sterilization).
The fermentation was carried out at 27°C for 192hours on a rotary shaker (210rpm). The culture broth (10 liters) was filtered using Celite and the culture filtrate was extracted with ethyl acetate. The mycelium was extracted with methanol and the extract was concentrated in vacuo to give an aqueous residue, which was then extracted with ethyl acetate. Both ethyl acetate extracts were combined and concentrated in vacuo to dryness. The crude extract (1.6g) was chromatographed on a silica gel column with chloroformmethanol (200: 1~100: 1 The NMRstudy of arisugacin revealed its structure as 3/-demethoxy-territrem B (Fig. 1) . The details of the structure elucidation will be reported elsewhere. The inhibitory activities of arisugacin against AChE (from human erythrocytes) and butyrylcholinesterase (BChE, from horse serum) are shown in respectively. On the other hand, the inhibitory activities of arisugacin and territrems B and C against BChE were more than 1,500 times weaker than that of tacrine. Since arisugacin is a highly selective inhibitor against AChE, it is expected to be effectivein Alzheimer's disease, too.
